drugset / Trial / NCT01400607
Neocartilage Implant to Treat Cartilage Lesions of the Knee
RandomizedParallel-groupSingle-blindTreatment
Summary
ISTO Technologies, Inc. is proposing a clinical study with 225 subjects, to establish the safety and efficacy of the Neocartilage Implant for the treatment of ICRS Grade 3 and 4 articular cartilage lesions of the knee compared to microfracture treatment.
Timeline
- Start
- 2011-07
- Primary completion
- 2020-09
- Completion
- 2020-09
Outcome
Outcome not reported
Stopped (Enrollment): “Poor enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neocartilage Implant | Cell therapy | — | — |